Utility of cardiovascular magnetic resonance in the diagnosis of anderson-fabry disease

Circulation

Volumn 120, Issue 13, 2009, Pages

  Gange, Christopher A ^a   Link, Mark S ^a   Maron, Martin S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GADOLINIUM;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; DYSPNEA; ELECTROCARDIOGRAM; FABRY DISEASE; FATIGUE; HEART ATRIUM FIBRILLATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART PALPITATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SINUS ARRHYTHMIA; SUPRAVENTRICULAR TACHYCARDIA;

ELECTROCARDIOGRAPHY; FABRY DISEASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 70349667177     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.849828     Document Type: Article

References (4)

1. Moon JCC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease-specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24: 2151-2155.
2. Desnick RJ, Brady R, Barranger J, Collins AJ. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138:338.
3. Nagueh SF. Fabry disease. Heart. 2003;89:819.
4. Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. Improvement of cardiac function during enzyme replacement therapy in patients with Anderson-Fabry disease: a prospective strain rate imaging study. Circulation. 2003;108:1299-1301.